# FDA 483 - Solaris Pharmacy, Inc. - February 26, 2020

Source: https://www.keypedia.com/records/483/solaris-pharmacy-inc/c1d6c1dc-d32b-4101-9df4-e2df6cf9469f

> FDA 483 for Solaris Pharmacy, Inc. on February 26, 2020. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Solaris Pharmacy, Inc.
- Inspection Date: 2020-02-26
- Product Type: drugs
- Office Name: Dallas District Office
- Summary: Solaris Pharmacy, Inc. in Decatur, TX, was inspected by the FDA from February 19-26, 2020, and received two observations. The inspection revealed issues with unsuitable cleaning agents for non-sterile drug production and the use of non-pharmaceutical grade components in compounded drugs. These findings indicate significant concerns regarding the quality and safety of the firm's non-sterile drug products.

## Related Documents

- [483 - 2020-02-26](https://www.keypedia.com/records/483/solaris-pharmacy-inc/a836ac02-594c-4b5a-b2dd-12bbb9ac7c41)
- [145 - 2020-07-17](https://www.keypedia.com/records/145/solaris-pharmacy-inc/890c83b1-5f51-448f-9159-929154d3d3a5)

## Related Officers

- [Investigator](https://www.keypedia.com/people/patty-p-kaewussdangkul/1f0961fc-216e-4580-830a-56a76c0e7cea)

Company: https://www.keypedia.com/companies/solaris-pharmacy-inc/2473951b-c51c-4977-8e1a-469b285d46a8

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9